Evidence map›Paper›PMID 26945064›Full record

ArticleThe Journal of biological chemistry2016

The Most Prevalent Freeman-Sheldon Syndrome Mutations in the Embryonic Myosin Motor Share Functional Defects.

Jonathan Walklate, Carlos Vera, Marieke J Bloemink, Michael A Geeves, Leslie Leinwand

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Homologous mutations in human β, embryonic, and perinatal muscle myosins have divergent effects on molecular power generation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Defective sarcomere organization and reduced larval locomotion and fish survival in slow muscle heavy chain 1 (smyhc1) mutants.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Freeman-Burian syndrome.Orphanet journal of rare diseases · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jonathan WalklateFrom the School of Biosciences, University of Kent, Canterbury CT2 7NJ, United Kingdom and.
Carlos Verathe Department of Molecular and Developmental Biology, University of Colorado, Boulder, Colorado 80309.
Marieke J BloeminkFrom the School of Biosciences, University of Kent, Canterbury CT2 7NJ, United Kingdom and.
Michael A GeevesFrom the School of Biosciences, University of Kent, Canterbury CT2 7NJ, United Kingdom and M.A.Geeves@kent.ac.uk.
Leslie Leinwandthe Department of Molecular and Developmental Biology, University of Colorado, Boulder, Colorado 80309 leslie.leinwand@Colorado.edu.
University of Kent · GBUniversity of Colorado Boulder · US

Funding

MYOSIN GENE DIVERSITY AND FUNCTIONR01GM029090 · NIGMS · YESHIVA UNIVERSITY · PI Leslie Anne Leinwand · 1985 to 2026
$12.3M
NIGMS NIH HHS R01 GM029090Wellcome Trust 085309
6 · The paper itself

Abstract

The embryonic myosin isoform is expressed during fetal development and rapidly down-regulated after birth. Freeman-Sheldon syndrome (FSS) is a disease associated with missense mutations in the motor domain of this myosin. It is the most severe form of distal arthrogryposis, leading to overcontraction of the hands, feet, and orofacial muscles and other joints of the body. Availability of human embryonic muscle tissue has been a limiting factor in investigating the properties of this isoform and its mutations. Using a recombinant expression system, we have studied homogeneous samples of human motors for the WT and three of the most common FSS mutants: R672H, R672C, and T178I. Our data suggest that the WT embryonic myosin motor is similar in contractile speed to the slow type I/β cardiac based on the rate constant for ADP release and ADP affinity for actin-myosin. All three FSS mutations show dramatic changes in kinetic properties, most notably the slowing of the apparent ATP hydrolysis step (reduced 5-9-fold), leading to a longer lived detached state and a slowed Vmax of the ATPase (2-35-fold), indicating a slower cycling time. These mutations therefore seriously disrupt myosin function.

Indexed as

Adenosine TriphosphatasesAdenosine TriphosphateCells, CulturedCraniofacial DysostosisCytoskeletal ProteinsEmbryonic Germ CellsHumansHydrolysisMuscle ContractionMutationMyosin SubfragmentsProtein IsoformsAdenosine TriphosphatasesAdenosine TriphosphateCytoskeletal ProteinsMYH3 polypeptide, humanMyosin SubfragmentsProtein IsoformsATPaseenzyme kineticshuman myosinmolecular motormuscle diseasemyosin subfragment 1recombinant protein expressionskeletal muscletransient kinetics

Identifiers

PMID26945064
PMCPMC4858979
OpenAlexW2290332073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.